網膜色素変性症治療の世界市場 2020年

• 英文タイトル：Global Retinitis Pigmentosa Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115037 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、網膜色素変性症治療の世界市場を調査対象にし、網膜色素変性症治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（BNP-RP、セネゲルミン、CPK-850、クタメシン、FAB-111、その他）、用途別分析（病院、クリニック、在宅医療）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Astellas Pharma Inc.、ID Pharma Co., Ltd.、Genable Technologies Limited、Caladrius Biosciences, Inc.、Grupo Ferrer Internacional, S.A.、Dompe Farmaceutici S.p.A.、International Stem Cell Corporation、GenSight Biologics S.A.、Genethon、InFlectis BioScience、Orphagen Pharmaceuticals, Inc.、Ionis Pharmaceuticals, Inc.、Nanovector s.r.l.、M's Science Corporation、Mimetogen Pharmaceuticals Inc. ・企業別売上、市場シェア ・網膜色素変性症治療の地域別市場分析 ・網膜色素変性症治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・網膜色素変性症治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・網膜色素変性症治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・網膜色素変性症治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・網膜色素変性症治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・網膜色素変性症治療の種類別市場規模2015-2020：BNP-RP、セネゲルミン、CPK-850、クタメシン、FAB-111、その他 ・網膜色素変性症治療の用途別市場規模2015-2020：病院、クリニック、在宅医療 ・網膜色素変性症治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Retinitis Pigmentosa Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Retinitis Pigmentosa Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Retinitis Pigmentosa Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Retinitis Pigmentosa Treatment market has been segmented into:
BNP-RP
Cenegermin
CPK-850
Cutamesine
FAB-111
Others

By Application, Retinitis Pigmentosa Treatment has been segmented into:
Hospital
Clinic
Homecare

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Retinitis Pigmentosa Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Retinitis Pigmentosa Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Retinitis Pigmentosa Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Retinitis Pigmentosa Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Retinitis Pigmentosa Treatment Market Share Analysis
Retinitis Pigmentosa Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Retinitis Pigmentosa Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Retinitis Pigmentosa Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Retinitis Pigmentosa Treatment are:
Astellas Pharma Inc.
ID Pharma Co., Ltd.
Genable Technologies Limited
Caladrius Biosciences, Inc.
Grupo Ferrer Internacional, S.A.
Dompe Farmaceutici S.p.A.
International Stem Cell Corporation
GenSight Biologics S.A.
Genethon
InFlectis BioScience
Orphagen Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Nanovector s.r.l.
M’s Science Corporation
Mimetogen Pharmaceuticals Inc.

レポート目次

---

Table of Contents

1 Retinitis Pigmentosa Treatment Market Overview
1.1 Product Overview and Scope of Retinitis Pigmentosa Treatment
1.2 Classification of Retinitis Pigmentosa Treatment by Type
1.2.1 Global Retinitis Pigmentosa Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Retinitis Pigmentosa Treatment Revenue Market Share by Type in 2019
1.2.3 BNP-RP
1.2.4 Cenegermin
1.2.5 CPK-850
1.2.6 Cutamesine
1.2.7 FAB-111
1.2.8 Others
1.3 Global Retinitis Pigmentosa Treatment Market by Application
1.3.1 Overview: Global Retinitis Pigmentosa Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Homecare
1.4 Global Retinitis Pigmentosa Treatment Market by Regions
1.4.1 Global Retinitis Pigmentosa Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Retinitis Pigmentosa Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Retinitis Pigmentosa Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Retinitis Pigmentosa Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Retinitis Pigmentosa Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Retinitis Pigmentosa Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Retinitis Pigmentosa Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Astellas Pharma Inc.
2.1.1 Astellas Pharma Inc. Details
2.1.2 Astellas Pharma Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Astellas Pharma Inc. SWOT Analysis
2.1.4 Astellas Pharma Inc. Product and Services
2.1.5 Astellas Pharma Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 ID Pharma Co., Ltd.
2.2.1 ID Pharma Co., Ltd. Details
2.2.2 ID Pharma Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 ID Pharma Co., Ltd. SWOT Analysis
2.2.4 ID Pharma Co., Ltd. Product and Services
2.2.5 ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Genable Technologies Limited
2.3.1 Genable Technologies Limited Details
2.3.2 Genable Technologies Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Genable Technologies Limited SWOT Analysis
2.3.4 Genable Technologies Limited Product and Services
2.3.5 Genable Technologies Limited Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Caladrius Biosciences, Inc.
2.4.1 Caladrius Biosciences, Inc. Details
2.4.2 Caladrius Biosciences, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Caladrius Biosciences, Inc. SWOT Analysis
2.4.4 Caladrius Biosciences, Inc. Product and Services
2.4.5 Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Grupo Ferrer Internacional, S.A.
2.5.1 Grupo Ferrer Internacional, S.A. Details
2.5.2 Grupo Ferrer Internacional, S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Grupo Ferrer Internacional, S.A. SWOT Analysis
2.5.4 Grupo Ferrer Internacional, S.A. Product and Services
2.5.5 Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Dompe Farmaceutici S.p.A.
2.6.1 Dompe Farmaceutici S.p.A. Details
2.6.2 Dompe Farmaceutici S.p.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Dompe Farmaceutici S.p.A. SWOT Analysis
2.6.4 Dompe Farmaceutici S.p.A. Product and Services
2.6.5 Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 International Stem Cell Corporation
2.7.1 International Stem Cell Corporation Details
2.7.2 International Stem Cell Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 International Stem Cell Corporation SWOT Analysis
2.7.4 International Stem Cell Corporation Product and Services
2.7.5 International Stem Cell Corporation Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 GenSight Biologics S.A.
2.8.1 GenSight Biologics S.A. Details
2.8.2 GenSight Biologics S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GenSight Biologics S.A. SWOT Analysis
2.8.4 GenSight Biologics S.A. Product and Services
2.8.5 GenSight Biologics S.A. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Genethon
2.9.1 Genethon Details
2.9.2 Genethon Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Genethon SWOT Analysis
2.9.4 Genethon Product and Services
2.9.5 Genethon Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 InFlectis BioScience
2.10.1 InFlectis BioScience Details
2.10.2 InFlectis BioScience Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 InFlectis BioScience SWOT Analysis
2.10.4 InFlectis BioScience Product and Services
2.10.5 InFlectis BioScience Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Orphagen Pharmaceuticals, Inc.
2.11.1 Orphagen Pharmaceuticals, Inc. Details
2.11.2 Orphagen Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Orphagen Pharmaceuticals, Inc. SWOT Analysis
2.11.4 Orphagen Pharmaceuticals, Inc. Product and Services
2.11.5 Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Ionis Pharmaceuticals, Inc.
2.12.1 Ionis Pharmaceuticals, Inc. Details
2.12.2 Ionis Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Ionis Pharmaceuticals, Inc. SWOT Analysis
2.12.4 Ionis Pharmaceuticals, Inc. Product and Services
2.12.5 Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Nanovector s.r.l.
2.13.1 Nanovector s.r.l. Details
2.13.2 Nanovector s.r.l. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Nanovector s.r.l. SWOT Analysis
2.13.4 Nanovector s.r.l. Product and Services
2.13.5 Nanovector s.r.l. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 M’s Science Corporation
2.14.1 M’s Science Corporation Details
2.14.2 M’s Science Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 M’s Science Corporation SWOT Analysis
2.14.4 M’s Science Corporation Product and Services
2.14.5 M’s Science Corporation Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Mimetogen Pharmaceuticals Inc.
2.15.1 Mimetogen Pharmaceuticals Inc. Details
2.15.2 Mimetogen Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Mimetogen Pharmaceuticals Inc. SWOT Analysis
2.15.4 Mimetogen Pharmaceuticals Inc. Product and Services
2.15.5 Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Retinitis Pigmentosa Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Retinitis Pigmentosa Treatment Players Market Share
3.2.2 Top 10 Retinitis Pigmentosa Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Retinitis Pigmentosa Treatment Revenue and Market Share by Regions
4.2 North America Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
5 North America Retinitis Pigmentosa Treatment Revenue by Countries
5.1 North America Retinitis Pigmentosa Treatment Revenue by Countries (2015-2020)
5.2 USA Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
6 Europe Retinitis Pigmentosa Treatment Revenue by Countries
6.1 Europe Retinitis Pigmentosa Treatment Revenue by Countries (2015-2020)
6.2 Germany Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
6.4 France Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Countries
7.1 Asia-Pacific Retinitis Pigmentosa Treatment Revenue by Countries (2015-2020)
7.2 China Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
7.5 India Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
8 South America Retinitis Pigmentosa Treatment Revenue by Countries
8.1 South America Retinitis Pigmentosa Treatment Revenue by Countries (2015-2020)
8.2 Brazil Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Retinitis Pigmentosa Treatment by Countries
9.1 Middle East & Africa Retinitis Pigmentosa Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Retinitis Pigmentosa Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Retinitis Pigmentosa Treatment Market Forecast by Type (2019-2024)
10.3 BNP-RP Revenue Growth Rate (2015-2025)
10.4 Cenegermin Revenue Growth Rate (2015-2025)
10.5 CPK-850 Revenue Growth Rate (2015-2025)
10.6 Cutamesine Revenue Growth Rate (2015-2025)
10.7 FAB-111 Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Retinitis Pigmentosa Treatment Market Segment by Application
11.1 Global Retinitis Pigmentosa Treatment Revenue Market Share by Application (2015-2020)
11.2 Retinitis Pigmentosa Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Homecare Revenue Growth (2015-2020)
12 Global Retinitis Pigmentosa Treatment Market Size Forecast (2021-2025)
12.1 Global Retinitis Pigmentosa Treatment Market Size Forecast (2021-2025)
12.2 Global Retinitis Pigmentosa Treatment Market Forecast by Regions (2021-2025)
12.3 North America Retinitis Pigmentosa Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Retinitis Pigmentosa Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Retinitis Pigmentosa Treatment Revenue Market Forecast (2021-2025)
12.6 South America Retinitis Pigmentosa Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Retinitis Pigmentosa Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Retinitis Pigmentosa Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Retinitis Pigmentosa Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Retinitis Pigmentosa Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Retinitis Pigmentosa Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Astellas Pharma Inc. Corporate Information, Location and Competitors
Table 6. Astellas Pharma Inc. Retinitis Pigmentosa Treatment Major Business
Table 7. Astellas Pharma Inc. Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Astellas Pharma Inc. SWOT Analysis
Table 9. Astellas Pharma Inc. Retinitis Pigmentosa Treatment Product and Solutions
Table 10. Astellas Pharma Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. ID Pharma Co., Ltd. Corporate Information, Location and Competitors
Table 12. ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Major Business
Table 13. ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2018-2019)
Table 14. ID Pharma Co., Ltd. SWOT Analysis
Table 15. ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Product and Solutions
Table 16. ID Pharma Co., Ltd. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Genable Technologies Limited Corporate Information, Location and Competitors
Table 18. Genable Technologies Limited Retinitis Pigmentosa Treatment Major Business
Table 19. Genable Technologies Limited Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Genable Technologies Limited SWOT Analysis
Table 21. Genable Technologies Limited Retinitis Pigmentosa Treatment Product and Solutions
Table 22. Genable Technologies Limited Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Caladrius Biosciences, Inc. Corporate Information, Location and Competitors
Table 24. Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Major Business
Table 25. Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Caladrius Biosciences, Inc. SWOT Analysis
Table 27. Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Product and Solutions
Table 28. Caladrius Biosciences, Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Grupo Ferrer Internacional, S.A. Corporate Information, Location and Competitors
Table 30. Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Major Business
Table 31. Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Grupo Ferrer Internacional, S.A. SWOT Analysis
Table 33. Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Product and Solutions
Table 34. Grupo Ferrer Internacional, S.A. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Dompe Farmaceutici S.p.A. Corporate Information, Location and Competitors
Table 36. Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Major Business
Table 37. Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Dompe Farmaceutici S.p.A. SWOT Analysis
Table 39. Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Product and Solutions
Table 40. Dompe Farmaceutici S.p.A. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. International Stem Cell Corporation Corporate Information, Location and Competitors
Table 42. International Stem Cell Corporation Retinitis Pigmentosa Treatment Major Business
Table 43. International Stem Cell Corporation Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 44. International Stem Cell Corporation SWOT Analysis
Table 45. International Stem Cell Corporation Retinitis Pigmentosa Treatment Product and Solutions
Table 46. International Stem Cell Corporation Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. GenSight Biologics S.A. Corporate Information, Location and Competitors
Table 48. GenSight Biologics S.A. Retinitis Pigmentosa Treatment Major Business
Table 49. GenSight Biologics S.A. Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 50. GenSight Biologics S.A. SWOT Analysis
Table 51. GenSight Biologics S.A. Retinitis Pigmentosa Treatment Product and Solutions
Table 52. GenSight Biologics S.A. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Genethon Corporate Information, Location and Competitors
Table 54. Genethon Retinitis Pigmentosa Treatment Major Business
Table 55. Genethon Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Genethon SWOT Analysis
Table 57. Genethon Retinitis Pigmentosa Treatment Product and Solutions
Table 58. Genethon Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. InFlectis BioScience Corporate Information, Location and Competitors
Table 60. InFlectis BioScience Retinitis Pigmentosa Treatment Major Business
Table 61. InFlectis BioScience Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 62. InFlectis BioScience SWOT Analysis
Table 63. InFlectis BioScience Retinitis Pigmentosa Treatment Product and Solutions
Table 64. InFlectis BioScience Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Orphagen Pharmaceuticals, Inc. Corporate Information, Location and Competitors
Table 66. Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Major Business
Table 67. Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Orphagen Pharmaceuticals, Inc. SWOT Analysis
Table 69. Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product and Solutions
Table 70. Orphagen Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Ionis Pharmaceuticals, Inc. Corporate Information, Location and Competitors
Table 72. Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Major Business
Table 73. Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 74. Ionis Pharmaceuticals, Inc. SWOT Analysis
Table 75. Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Product and Solutions
Table 76. Ionis Pharmaceuticals, Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Nanovector s.r.l. Corporate Information, Location and Competitors
Table 78. Nanovector s.r.l. Retinitis Pigmentosa Treatment Major Business
Table 79. Nanovector s.r.l. Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 80. Nanovector s.r.l. SWOT Analysis
Table 81. Nanovector s.r.l. Retinitis Pigmentosa Treatment Product and Solutions
Table 82. Nanovector s.r.l. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. M's Science Corporation Corporate Information, Location and Competitors
Table 84. M's Science Corporation Retinitis Pigmentosa Treatment Major Business
Table 85. M's Science Corporation Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 86. M's Science Corporation SWOT Analysis
Table 87. M's Science Corporation Retinitis Pigmentosa Treatment Product and Solutions
Table 88. M's Science Corporation Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Mimetogen Pharmaceuticals Inc. Corporate Information, Location and Competitors
Table 90. Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Major Business
Table 91. Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Total Revenue (USD Million) (2017-2018)
Table 92. Mimetogen Pharmaceuticals Inc. SWOT Analysis
Table 93. Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Product and Solutions
Table 94. Mimetogen Pharmaceuticals Inc. Retinitis Pigmentosa Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Retinitis Pigmentosa Treatment Revenue (Million USD) by Players (2015-2020)
Table 96. Global Retinitis Pigmentosa Treatment Revenue Share by Players (2015-2020)
Table 97. Global Retinitis Pigmentosa Treatment Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Retinitis Pigmentosa Treatment Revenue Market Share by Regions (2015-2020)
Table 99. North America Retinitis Pigmentosa Treatment Revenue by Countries (2015-2020)
Table 100. North America Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2015-2020)
Table 101. Europe Retinitis Pigmentosa Treatment Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Retinitis Pigmentosa Treatment Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Retinitis Pigmentosa Treatment Revenue by Countries (2015-2020)
Table 104. South America Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Retinitis Pigmentosa Treatment Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2015-2020)
Table 107. Global Retinitis Pigmentosa Treatment Revenue (Million USD) by Type (2015-2020)
Table 108. Global Retinitis Pigmentosa Treatment Revenue Share by Type (2015-2020)
Table 109. Global Retinitis Pigmentosa Treatment Revenue Forecast by Type (2021-2025)
Table 110. Global Retinitis Pigmentosa Treatment Revenue by Application (2015-2020)
Table 111. Global Retinitis Pigmentosa Treatment Revenue Share by Application (2015-2020)
Table 112. Global Retinitis Pigmentosa Treatment Revenue Forecast by Application (2021-2025)
Table 113. Global Retinitis Pigmentosa Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Retinitis Pigmentosa Treatment Picture
Figure 2. Global Retinitis Pigmentosa Treatment Revenue Market Share by Type in 2019
Figure 3. BNP-RP Picture
Figure 4. Cenegermin Picture
Figure 5. CPK-850 Picture
Figure 6. Cutamesine Picture
Figure 7. FAB-111 Picture
Figure 8. Others Picture
Figure 9. Retinitis Pigmentosa Treatment Revenue Market Share by Application in 2019
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Homecare Picture
Figure 13. Global Retinitis Pigmentosa Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Retinitis Pigmentosa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Retinitis Pigmentosa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Retinitis Pigmentosa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Retinitis Pigmentosa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Retinitis Pigmentosa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Retinitis Pigmentosa Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Retinitis Pigmentosa Treatment Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Retinitis Pigmentosa Treatment Revenue Market Share in 2019
Figure 22. Global Top 10 Players Retinitis Pigmentosa Treatment Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Retinitis Pigmentosa Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Retinitis Pigmentosa Treatment Revenue Market Share by Regions (2015-2020)
Figure 26. Global Retinitis Pigmentosa Treatment Revenue Market Share by Regions in 2018
Figure 27. North America Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Europe Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 30. South America Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 32. North America Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. North America Retinitis Pigmentosa Treatment Revenue Market Share by Countries in 2019
Figure 34. USA Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Canada Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Europe Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Retinitis Pigmentosa Treatment Revenue Market Share by Countries in 2019
Figure 39. Germany Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 40. UK Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 41. France Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Russia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Italy Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Retinitis Pigmentosa Treatment Revenue Market Share by Countries in 2019
Figure 46. China Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Japan Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Korea Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 49. India Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 51. South America Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. South America Retinitis Pigmentosa Treatment Revenue Market Share by Countries in 2019
Figure 53. Brazil Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Retinitis Pigmentosa Treatment Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Retinitis Pigmentosa Treatment Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 58. UAE Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Retinitis Pigmentosa Treatment Revenue and Growth Rate (2015-2020)
Figure 61. Global Retinitis Pigmentosa Treatment Revenue Share by Type (2015-2020)
Figure 62. Global Retinitis Pigmentosa Treatment Revenue Share by Type in 2019
Figure 63. Global Retinitis Pigmentosa Treatment Market Share Forecast by Type (2021-2025)
Figure 64. Global BNP-RP Revenue Growth Rate (2015-2020)
Figure 65. Global Cenegermin Revenue Growth Rate (2015-2020)
Figure 66. Global CPK-850 Revenue Growth Rate (2015-2020)
Figure 67. Global Cutamesine Revenue Growth Rate (2015-2020)
Figure 68. Global FAB-111 Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Retinitis Pigmentosa Treatment Revenue Share by Application (2015-2020)
Figure 71. Global Retinitis Pigmentosa Treatment Revenue Share by Application in 2019
Figure 72. Global Retinitis Pigmentosa Treatment Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospital Revenue Growth Rate (2015-2020)
Figure 74. Global Clinic Revenue Growth Rate (2015-2020)
Figure 75. Global Homecare Revenue Growth Rate (2015-2020)
Figure 76. Global Retinitis Pigmentosa Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Retinitis Pigmentosa Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Retinitis Pigmentosa Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Retinitis Pigmentosa Treatment Revenue Market Forecast (2021-2025)
Figure 80. Europe Retinitis Pigmentosa Treatment Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Retinitis Pigmentosa Treatment Revenue Market Forecast (2021-2025)
Figure 82. South America Retinitis Pigmentosa Treatment Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Retinitis Pigmentosa Treatment Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel

---